Padayhag, Wenrite R.
HRN: 25-25-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2024
CEFTRIAXONE 1G (VIAL)
06/09/2024
06/16/2024
IV
2g
Q24
Lacerated Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes